SCHEMBL14160201

SCHEMBL14160201

C=C(c1ccc(I)cc1)c1ccc(I)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.55
HTT P42858 1/20 0.55
GFER P55789 1/20 0.55
HSD17B10 Q99714 1/20 0.55
GPR55 Q9Y2T6 1/20 0.55
TPMT P51580 1/20 0.50
CA1 P00915 3/20 0.48
CA2 P00918 3/20 0.48
GSK3B P49841 1/20 0.42
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
SLC22A2 O15244 1/20 0.35
SLC22A1 O15245 1/20 0.35
SLC22A3 O75751 1/20 0.35
PTPN2 P17706 1/20 0.33
PTPN1 P18031 1/20 0.33
FAAH O00519 1/20 0.33
MGLL Q99685 1/20 0.33
APP P05067 1/20 0.33
TRPV1 Q8NER1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14335633 0.82 APP (0.51) MAPTCA1CA2APP
SCHEMBL10227408 0.77 TPMT (0.46) MAPTHTTGFERHSD17B10GPR55
SCHEMBL12954769 0.77 TPMT (0.46) MAPTHTTGFERHSD17B10GPR55
SCHEMBL13364021 0.77 TPMT (0.46) MAPTHTTGFERHSD17B10GPR55
SCHEMBL4083603 0.73 TPMT (0.55) TPMTCA1CA2GSK3BSLC22A2
SCHEMBL2954412 0.73 TPMT (0.55) TPMTCA1CA2GSK3BMEN1
SCHEMBL8257656 0.73 TPMT (0.42) TPMTCA1CA2GSK3BRXRA
SCHEMBL824903 0.71 MAPT (1.00) MAPTHTTGFERHSD17B10GPR55
SCHEMBL894135 0.71 MEN1 (0.65) MAPTHTTGFERHSD17B10GPR55
SCHEMBL10942166 0.71 MAPT (1.00) MAPTHTTGFERHSD17B10GPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1930308-A1 Pharmaceutical agents for the treatment of cerebral amyloidosis NYMOX CORPORATION (CA) 2008-06-11 EP disclosed